Replies to post #418432 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

. If the data were negative, as in a failed trial, disclosure is the law, and they would have done it or faced lawsuits and potential jail time.

There is no such law.

The form 8-K lists the specific issues that force a 4 day disclosure. Negative material news is not on it.

The only specific clause that anybody making this assertion every cited was "material impairment", but that is an accounting term and would not be triggered by a failed trial.

In the case Anders loved to cite, the company did issue a PR. The PR was that they had a meeting with the FDA and were proceeding towards a BLA. But they failed to disclose that at the meeting the FDA said they had huge issue with more deaths on treatment than comparison arm. Thus, the PR was lying by omission.

And that is WHY LP goes silent on issue after issue. If they say anything about an IA, the endpoints, the FDA pre-BLA meeting or such then they have to fully disclose any negative material items that would be relevant to the PR'd issue. And that, LP will not do.

[newman2021]

Correct. Quiet Period means positive. This long quite period is even more convincing. And DI's determination to take it to the market means no failure of SEC disclosure.

[FeMike]

If the data were negative, as in a failed trial, disclosure is the law, and they would have done it or faced lawsuits and potential jail time.

This is one of the things keeping me a bit further from the ledge.

However, NWBO is headed by lawyers and know how to play the game. I still maintain there is a real possibility that they will not claim to have been officially unblinded until just before results are released. Thereby releasing them from the disclosure obligation.